220 related articles for article (PubMed ID: 16984690)
1. Analysis of the pharmaceuticals market and its technological development in Turkey.
Kisa A
Int J Technol Assess Health Care; 2006; 22(4):537-42. PubMed ID: 16984690
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
3. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
4. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
Gascón F; de la Fuente D; Puente J; Lozano J
Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
[TBL] [Abstract][Full Text] [Related]
5. Market uptake of biologic and small-molecule--targeted oncology drugs in Europe.
Obradovic M; Mrhar A; Kos M
Clin Ther; 2009 Dec; 31(12):2940-52. PubMed ID: 20110034
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical sector in transition--a cross sectional study in Vietnam.
Falkenberg T; Nguyen TB; Larsson M; Nguyen TD; Tomson G
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):590-7. PubMed ID: 11289028
[TBL] [Abstract][Full Text] [Related]
7. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
Martikainen J; Kivi I; Linnosmaa I
Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
[TBL] [Abstract][Full Text] [Related]
8. Reference pricing of pharmaceuticals.
Brekke KR; Königbauer I; Straume OR
J Health Econ; 2007 May; 26(3):613-42. PubMed ID: 17188769
[TBL] [Abstract][Full Text] [Related]
9. [The drug trade between European countries and developing countries].
Bruneton C; Naboulet P; van der Heide B; Rey JL
Med Trop (Mars); 1997; 57(4):375-9. PubMed ID: 9612781
[TBL] [Abstract][Full Text] [Related]
10. Generic medicine pricing in Europe: current issues and future perspective.
Simoens S
J Med Econ; 2008; 11(1):171-5. PubMed ID: 19450118
[TBL] [Abstract][Full Text] [Related]
11. The rise of the generic drug market and its implications for dermatology.
Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
[TBL] [Abstract][Full Text] [Related]
12. [Strategies for pharmaceutical research and development. II. Generic drugs].
Kuchar M
Ceska Slov Farm; 1996 Jul; 45(4):171-6. PubMed ID: 8925240
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. The performance and problems of the Turkish pharmaceutical industry: is there a need to develop a national drug policy?
Kisa A
J Med Syst; 2001 Oct; 25(5):309-18. PubMed ID: 11508904
[TBL] [Abstract][Full Text] [Related]
15. Cost containment through pharmaceutical procurement: a Caribbean case study.
Huff-Rousselle M; Burnett F
Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681
[TBL] [Abstract][Full Text] [Related]
16. Does brand differentiate pharmaceuticals?
Bednarik J
Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
[TBL] [Abstract][Full Text] [Related]
17. [Bioequivalence studies of pharmaceutical preparations].
Vetchý D; Frýbortová K; Rabisková M; Danecková H
Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
[TBL] [Abstract][Full Text] [Related]
18. Is the pharmaceutical market in Bulgaria innovative?
Stoimenova A; Stankova M; Samev K; Petrova G
Boll Chim Farm; 2003 Sep; 142(7):260-3. PubMed ID: 14677267
[TBL] [Abstract][Full Text] [Related]
19. Analysis of strengths, weaknesses, opportunities, and threats in the development of a health technology assessment program in Turkey.
Kahveci R; Meads C
Int J Technol Assess Health Care; 2008; 24(2):235-40. PubMed ID: 18400128
[TBL] [Abstract][Full Text] [Related]
20. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
Morgan S; McMahon M; Greyson D
Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
